Topos Bio
PrivateLast Round
Seed
Jan 8, 2026
Total Funding Raised
$10.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Topos Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in January 2026.
Topos Bio is a biotechnology company that develops an AI-powered drug discovery platform for targeting intrinsically disordered proteins involved in diseases such as neurodegeneration and oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Topos Bio Comparables
Compare Topos Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Peptone | 83% | |
| Fathom Therapeutics | 82% | |
| Post Translational Medicines | 82% |
For institutional investors. Book with your work email.
Topos Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Topos Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KF Ventures | Seed |
| Boldstart Ventures | Seed |
| Neo | Seed |
| Threshold Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 186% MoM, reaching 3.3K.
- Jun 24, 2026
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Topos Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Topos Bio's valuation, stock price, and market status.
Is Topos Bio a public or private company?
Topos Bio is a private company.
What is the current stock price of Topos Bio?
Topos Bio is a private company, so its shares have no public market price. Caplight tracks Topos Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Topos Bio worth (valuation)?
Valuation information for Topos Bio is not publicly available.
Can I buy Topos Bio stock?
Topos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Topos Bio's last funding round?
Topos Bio's most recent funding round was Seed on January 8, 2026.
Who are the main investors in Topos Bio?
Key investors in Topos Bio include Boldstart Ventures, Neo, Threshold Ventures.
Will Topos Bio IPO soon?
No public IPO plans have been announced for Topos Bio.
How can I track Topos Bio secondary market activity?
Caplight tracks bids, offers, and trades in Topos Bio's shares on secondary markets.